Respiratory Pathogen Nucleic Acid Detection Testing
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy CS379.C alerts
Get alerted when Policy CS379.C changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of respiratory pathogen molecular testing, including multiplex nucleic acid amplification and metagenomic next-generation sequencing. In outpatient settings, respiratory pathogen panel testing that detects six or more targets is considered unproven and not medically necessary for all indications.
The applicable CPT code list was updated to reflect quarterly edits.
CPT code 0556U was removed from the applicable code list.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.